There is little time left for Plus Therapeutics Inc (PSTV) to reach its 1-year target estimate. How soon will it surpass it?
Plus Therapeutics Inc (NASDAQ:PSTV) shares traded 17.65% higher at $1.60 on Wall Street last session. In accordance with the data, 4 analysts cover Plus Therapeutics Inc (NASDAQ:PSTV). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and a low of $4.00, […]
Before You Invest In Plus Therapeutics Inc. (NASDAQ:PSTV), Consider This Metric
Stocks of Plus Therapeutics Inc. (NASDAQ:PSTV) traded higher last session on Wall Street, down -53.54% to $1.38. According to the data, Plus Therapeutics Inc. (NASDAQ:PSTV) has 4 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and […]